Antitrust Antitrust

Servier's market-dominance court victory endangers antitrust law, EU Commission argues

By Nicholas Hirst
  • 21 Oct 2021 12:13
  • 21 Oct 2021 12:13
The price stability of Servier's blockbuster perindopril drug in the face of market developments is evidence of the French drugmaker's dominance, the European Commission argued today at the EU's top court.

It is trying to overturn a ruling by the General Court, which largely upheld a 2014 decision against Servier and

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News